Psychopathology and urine toxicology in methadone patients

Gamal Sadek (Methadone Clinic, London, ON;)
Zack Cernovsky (Department of Psychiatry, University of Western Ontario, ON, Canada)
Simon Chiu (Department of Psychiatry, University of Western Ontario, ON, Canada)

Mental Illness

ISSN: 2036-7465

Article publication date: 24 February 2015

This content is currently only available as a PDF


Several studies reported high rates of psychiatric commorbidity among methadone patients. We examined the relationships of measures of psychopathology to outcomes of screening urine tests for cocaine, opiates, and benzodiazepines in a sample of 56 methadone patients. They also completed the Symptom Check List-90-Revised (SCL-90-R). The highest scales in the SCL-90-R profile of our patients were those indicating somatic discomfort, anger, phobic anxiety, paranoid ideation, and also obsessive-compulsive disorder symptoms (scores above the 39th per centile). The only significant correlations between urine tests and SCL-90-R psychopathology were those involving benzodiazepines: patients with urine tests positive for benzodiazepines had lower social self-confidence (r=0.48), were more obsessive-compulsive (r=0.44), reported a higher level of anger (r=0.41), of phobic tendencies (r=40), of anxiety (r=0.39), and of paranoid tendencies (r=0.38), and also reported more frequent psychotic symptoms (r=0.43).



Sadek, G., Cernovsky, Z. and Chiu, S. (2015), "Psychopathology and urine toxicology in methadone patients", Mental Illness, Vol. 7 No. 1, pp. 16-17.



Emerald Publishing Limited

Copyright © 2015 G. Sadek et al.


This work is licensed under a Creative Commons Attribution 3.0 License (by-nc 3.0).

Corresponding author

Zack Cernovsky, Psychiatric Clinic, 231 Wharncliffe Rd South, London, Ontario, N6J 2L3, Canada. Tel.: +1.519.4718049.

Related articles